Evidence map›Paper›PMID 32517455›Full record

ReviewZhongguo fei ai za zhi = Chinese journal of lung cancer2020

[Predictors for the Bronchiolitis Obliterans Syndrome in Lung Transplant Patient].

Sijia Yang, Abudumailamu Abuduwufuer, Wang Lv, Feichao Bao, Jian Hu

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sijia YangThe First Affiliated Hospital, Collage of Medicine, Zhejiang University, Hangzhou 310003, China.
Abudumailamu AbuduwufuerThe First Affiliated Hospital, Collage of Medicine, Zhejiang University, Hangzhou 310003, China.
Wang LvThe First Affiliated Hospital, Collage of Medicine, Zhejiang University, Hangzhou 310003, China.
Feichao BaoThe First Affiliated Hospital, Collage of Medicine, Zhejiang University, Hangzhou 310003, China.
Jian HuThe First Affiliated Hospital, Collage of Medicine, Zhejiang University, Hangzhou 310003, China.
First Affiliated Hospital Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung transplantation is the ultimate treatment of end-stage lung disease. After transplantation, the 1-year survival rate is 80%, while the 5-year survival rates remaines at around 50% mainly due to bronchiolitis obliterans syndrome (BOS). BOS is regarded as a fibrosing process in the small airways leading to irreversible airway obstruction. A lot of factors are involved in the development of BOS, such as Ischemia/reperfusion injury, infections, oxidative stress, and acute rejection, etc. Studies have shown that early diagnosis of BOS may improve outcome. It is valuable for the long-term survival of lung transplantation to find out several predictors for the BOS. This article reviews the current state of knowledge on predictors for BOS.

Indexed as

BiomarkersBronchiolitis ObliteransHumansLung TransplantationPrognosisBiomarkersBronchiolitis obliterans syndromeLung transplantationPredictor

Identifiers

PMID32517455
PMCPMC7309540
OpenAlexW3033456983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.